A California woman has filed a Zoloft lawsuit alleging the manufacturer of the drug committed fraud by marketing the drug as effective. Laura Plumlee has said that Pfizer withheld studies from the Food and Drug Administration (FDA) indicating that the antidepressant drug is about as effective as a placebo.
Zoloft and similar antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs) have been the increased focus of studies aimed at determining their efficacy and potential dangers. In addition to studies showing Zoloft may be only as effective as a placebo, many studies have linked the drug to potentially severe birth defects.
A study published in the New England Journal of Medicine found that women who use Zoloft during pregnancy are twice as likely to give birth to a child with heart defects. Other Zoloft birth defects include persistent pulmonary hypertension of the newborn, omphalocele and brain defects.